Other Content - BioPharm International

ADVERTISEMENT

Other Content

Waters - Method Development for the Separation of Sulfated Estrogens by UltraPerformance Convergence Chromatography(UPC2)

January 24, 2014

Waters - Method Development for the Separation of Sulfated Estrogens by UltraPerformance Convergence Chromatography(UPC2)

Vaisala - How to Conduct Better Stability Studies with FDA/ICH Guidance

January 21, 2014

Vaisala - How to Conduct Better Stability Studies with FDA/ICH Guidance

Agilent - Charge Variant Analysis using pH Gradients

January 21, 2014

Agilent - Charge Variant Analysis using pH Gradients

Thermo - LC/MS Analysis of the Monoclonal Antibody Rituximab

January 20, 2014

Thermo - LC/MS Analysis of the Monoclonal Antibody Rituximab

Waters - Separating Beyond Question

December 23, 2013

Waters - Separating Beyond Question

BioRad - Separation of Impurities in a Single Step using a Mixed-Mode Chromatography Media

December 23, 2013

BioRad - Separation of Impurities in a Single Step using a Mixed-Mode Chromatography Media

ProteinSimple - 10 Minute Charge Heterogeneity Analysis

December 20, 2013

ProteinSimple - 10 Minute Charge Heterogeneity Analysis

Agilent - Affinity Removal High Abundant Proteins in Human Plasma

December 11, 2013

Agilent - Affinity Removal High Abundant Proteins in Human Plasma

Wockhardt Receives FDA Warning Letter

December 6, 2013

FDA cites cGMP violations and data-integrity issues and raises concerns over the company's ability to implement a robust and sustainable quality system.

ADVERTISEMENT

ADVERTISEMENT

Click here